Suchergebnisse - "Horne, AnnaCarin"

PubPharm (95)

11

Population-based study of multisystem inflammatory syndrome associated with COVID-19 found that 36% of children had persistent symptoms

enthalten in: Acta paediatrica (Oslo, Norway : 1992) | 2022

von Kahn, R. | Berg, S. | Berntson, L. | +22

12

Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers : a single-center study

enthalten in: Pediatric rheumatology online journal | 2021

von Qu, H. | Sundberg, E. | Aulin, C. | +8

13

Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study

enthalten in: Pediatric rheumatology | 2021

von Qu, H. | Sundberg, E. | Aulin, C. | +8

14

Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study

enthalten in: Pediatric rheumatology | 2021

von Qu, H. | Sundberg, E. | Aulin, C. | +8

15

Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis

enthalten in: The Journal of rheumatology | 2021

von Horne, A. | von Bahr Greenwood, T. | Chiang, S. | +9

16

Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children : a retrospective cohort study

enthalten in: The Lancet. Rheumatology | 2021

von Kessel, C. | Fall, N. | Grom, A. | +18

17

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 : A Meta-analysis

enthalten in: JAMA | 2021

von WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group | Shankar-Hari, M. | Vale, C. | +165

CommentIn: JAMA. 2021 Aug 10;326(6):483-485. - PMID 34228779

18

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome

enthalten in: Molecular medicine (Cambridge, Mass.) | 2021

von Palmblad, K. | Schierbeck, H. | Sundberg, E. | +4

19

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome

enthalten in: Molecular medicine | 2021

von Palmblad, K. | Schierbeck, H. | Sundberg, E. | +4

20

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome

enthalten in: Molecular medicine | 2021

von Palmblad, K. | Schierbeck, H. | Sundberg, E. | +4